drugset
drugset / Trial / NCT01451996

The Efficacy of Claritin in Healthy Subjects

NCT01451996 ↗

Phase 4 Completed 340 enrolled University of Chicago
RandomizedParallel-groupTriple-blindOther

Summary

The primary goal of this study is to examine determinants of the efficacy of Claritin.

Timeline

Start
2011-10
Primary completion
2012-07
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Loratadine Small molecule 10 mg —

Indications

No indication recorded.